← Back to headlines
Medtronic's MiniMed Diabetes Unit Seeks Up to $784M in US IPO
Medtronic's diabetes unit, MiniMed, is reportedly seeking to raise up to $784 million through an initial public offering (IPO) in the U.S. market.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
